98 related articles for article (PubMed ID: 6189151)
1. [Critical study of acid phosphatases in benign prostatic hypertrophy].
Rodrigues Netto Júnior N; de Andrade AC; Lemos GC; de Araujo JT
AMB Rev Assoc Med Bras; 1982; 28(3-4):93-5. PubMed ID: 6189151
[No Abstract] [Full Text] [Related]
2. [Changes in acid phosphatase levels during various prostatic operations].
Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
[No Abstract] [Full Text] [Related]
3. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
Braun JS; Habig H; Crüsemann D
Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
[No Abstract] [Full Text] [Related]
4. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
Nakano S
Hinyokika Kiyo; 1969 Aug; 15(8):565-75. PubMed ID: 4186705
[No Abstract] [Full Text] [Related]
5. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
[TBL] [Abstract][Full Text] [Related]
6. [Total and tartrate-inhibited acid phosphatases in serum. Significance of rectal examination in normal individuals and patients with benign prostatic hypertrophy].
Nielsen ML; Christensen P; Antoni E
Ugeskr Laeger; 1971 Nov; 133(46):2279-84. PubMed ID: 4109415
[No Abstract] [Full Text] [Related]
7. [Determination of activity of acid phosphatase in serum in prostatic diseases].
Ianishevskaia AD
Lab Delo; 1967; 5():277-80. PubMed ID: 4184710
[No Abstract] [Full Text] [Related]
8. [Enzymological study of prostatic cancer. V. Alterations in the serum acid and alkaline phosphatase and leucine aminopeptidase activities following massage of the prostate].
Ishibe T
Nihon Hinyokika Gakkai Zasshi; 1972 Oct; 63(10):873-7. PubMed ID: 4119371
[No Abstract] [Full Text] [Related]
9. [Value of determining prostatic acid phosphatases by a radioimmunological method in cases of bony metastases].
Mattei JP; Imbert I; Laugier-Catenacci E; Roux H
Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):147-9. PubMed ID: 2471253
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
[TBL] [Abstract][Full Text] [Related]
11. [Serum acid phosphatase activity in pathology].
Paget M; Sanchez E; Vanneste A; Coustenoble P
J Sci Med Lille; 1972; 90(8):283-94. PubMed ID: 4118620
[No Abstract] [Full Text] [Related]
12. Prostate-specific acid phosphatase in Nigerian patients with prostate carcinoma.
Bolarin DM; Badejo OA
East Afr Med J; 1985 May; 62(5):332-7. PubMed ID: 2412782
[No Abstract] [Full Text] [Related]
13. [Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method].
Sakai S; Kato N; Shimazu R; Doi T; Shimizu Y; Kawada Y; Nishiura T; Sawada H
Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):609-18. PubMed ID: 6184513
[No Abstract] [Full Text] [Related]
14. Comparison of prostatic acid phosphatase assays.
Wise WS; Kandaswamy K
Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
[TBL] [Abstract][Full Text] [Related]
15. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Sharief FS; Mohler JL; Sharief Y; Li SS
Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
Okabe H; Noma A; Nakauchi K; Mori M
Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
[No Abstract] [Full Text] [Related]
17. The effect of rectal examination on serum acid phosphatase levels in benign and malignant prostatic disease.
Osegbe DN; Magoha G
Postgrad Med J; 1982 Dec; 58(686):763-6. PubMed ID: 6189110
[TBL] [Abstract][Full Text] [Related]
18. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
Perrin P; Clairet F; Fleury-Goyon MC; Durand L
J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
[TBL] [Abstract][Full Text] [Related]
19. Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
Petrovich G; Ursich-Jankovich J; Prijovich Z
Clin Chem; 1992 Feb; 38(2):276-7. PubMed ID: 1371723
[TBL] [Abstract][Full Text] [Related]
20. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
Hamami G
Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
